From: Hyperkalemia in a patient with myasthenia gravis: case presentation
No | Studies | Year | Sex | Age at MG onset (year) | Age at AD onset (year) | Symptom | Sodium (mEq/L) | Potassium (mEq/L) | PAS type 2 |
---|---|---|---|---|---|---|---|---|---|
1. | Bosh et al. [14] | 1977 | Female | 16 | 30 | Fatigue, weakness | 122 | 4.2 | Yes (Hypothyroidism) |
2 | Dumas et al. [4] | 1985 | Female | 48 | 35 | Diplopia | NA | NA | No |
3 | Dumas et al. [4] | 1985 | Male | 50 | 37 | Diplopia | NA | NA | No |
4 | McAlpine et al. [15] | 1988 | Female | 17 | 47 | Nausea, vomiting | 99 | 4.9 | Yes (Hypothyroidism) |
5 | Kane et al. [5] | 1950 | Male | 18 | 19 | Nausea, vomiting | 128 | 6.7 | No |
6 | Okada et al. [6] | 1994 | Female | 38 | 53 | Nausea, diarrhea | 113 | 3.8 | No |
7 | Seker et al. [17] | 2009 | Male | 32 | 32 | Weakness, vomiting | 144 | 3.8 | No |
8 | Knno et al. [16] | 2009 | Female | 74 | 61 | Vomiting, headache | 137 | 3.9 | Yes (autoimmune thyroid disease) |
9 | Our case | 2018 | Female | 55 | 57 | Fatigue, weakness | 128 | 5.6 | No |